Could Weight-Loss surgery slash heart risks in diabetes?

NCT ID NCT03955952

Completed Disease control Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This study looks at whether bariatric (weight-loss) surgery can reduce the risk of heart attacks, strokes, heart failure, and death in people who have both type 2 diabetes and obesity. It compares people who had the surgery with those who received usual diabetes care. The goal is to see if surgery offers extra protection for the heart and blood vessels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Bariatric surgery (weight-loss surgery)
What this could lead to: If successful, this could show that weight-loss surgery is a powerful way to reduce serious heart problems and early death in people with type 2 diabetes and obesity.
What could go wrong: This is an observational study, not a randomized trial, so results may be influenced by other factors. Surgery carries risks, and benefits may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY CANDIDATE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BARIATRIC SURGERY CANDIDATE OBESITY TYPE2 DIABETES

Contacts and locations

Locations

Cleveland Clinic

Cleveland, Ohio, 44195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.